1. Home
  2. SVRA vs LMB Comparison

SVRA vs LMB Comparison

Compare SVRA & LMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • LMB
  • Stock Information
  • Founded
  • SVRA N/A
  • LMB 1901
  • Country
  • SVRA United States
  • LMB United States
  • Employees
  • SVRA N/A
  • LMB N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • LMB Engineering & Construction
  • Sector
  • SVRA Health Care
  • LMB Consumer Discretionary
  • Exchange
  • SVRA Nasdaq
  • LMB Nasdaq
  • Market Cap
  • SVRA 739.1M
  • LMB 728.6M
  • IPO Year
  • SVRA N/A
  • LMB 2014
  • Fundamental
  • Price
  • SVRA $3.82
  • LMB $77.38
  • Analyst Decision
  • SVRA Strong Buy
  • LMB
  • Analyst Count
  • SVRA 5
  • LMB 0
  • Target Price
  • SVRA $12.00
  • LMB N/A
  • AVG Volume (30 Days)
  • SVRA 1.3M
  • LMB 144.8K
  • Earning Date
  • SVRA 11-07-2024
  • LMB 11-06-2024
  • Dividend Yield
  • SVRA N/A
  • LMB N/A
  • EPS Growth
  • SVRA N/A
  • LMB 51.92
  • EPS
  • SVRA N/A
  • LMB 2.15
  • Revenue
  • SVRA N/A
  • LMB $511,670,000.00
  • Revenue This Year
  • SVRA N/A
  • LMB $1.57
  • Revenue Next Year
  • SVRA N/A
  • LMB $11.78
  • P/E Ratio
  • SVRA N/A
  • LMB $36.07
  • Revenue Growth
  • SVRA N/A
  • LMB N/A
  • 52 Week Low
  • SVRA $3.12
  • LMB $26.76
  • 52 Week High
  • SVRA $5.70
  • LMB $82.21
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 35.17
  • LMB 64.43
  • Support Level
  • SVRA $3.77
  • LMB $73.13
  • Resistance Level
  • SVRA $4.33
  • LMB $77.25
  • Average True Range (ATR)
  • SVRA 0.22
  • LMB 3.34
  • MACD
  • SVRA -0.07
  • LMB -0.12
  • Stochastic Oscillator
  • SVRA 9.28
  • LMB 55.28

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a commercial specialty contractor in the fields of heating, ventilation, air conditioning, plumbing, electrical, and building controls for the design and construction of new and renovated buildings, maintenance services, energy retrofits, and equipment upgrades. It operates in two segments namely General Contractor Relationships (GCR) and Owner Direct Relationships (ODR). The company generates maximum revenue from the ODR segment.

Share on Social Networks: